Undersøgelserne omfattede over 10 000 børn, hvoraf ca. tre fjerdedele fik Infanrix Penta i henhold til forskellige tidsplaner.
The studies involved over 10,000 infants, about three quarters of whom received Infanrix Penta, given according to various time schedules.